Midway through trading Wednesday, the Dow traded down 0.30% to 35,648.39 while the NASDAQ rose 0.32% to 15,283.97. The S&P also fell, dropping 0.03% to 4,573.51.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 46,497,710 cases with around 759,930 deaths. India confirmed a total of at least 34,215,650 cases and 455,680 deaths, while Brazil reported over 21,748,980 COVID-19 cases with 606,290 deaths. In total, there were at least 245,403,800 cases of COVID-19 worldwide with more than 4,981,390 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Communication services shares gained by 0.8% on Wednesday. Meanwhile, top gainers in the sector included Qutoutiao Inc. QTT, up 6% and Stagwell Inc. STGW up 5%.
In trading on Wednesday, energy shares fell 1.5%.
Top Headline
The Coca-Cola Company KO reported better-than-expected results for its third quarter.
Coca-Cola reported quarterly adjusted earnings of $0.65 per share, exceeding analysts’ estimates of $0.58 per share. The company’s sales came in at $10.00 billion, versus expectations of $9.75 billion.
Equities Trading UP
AgriFORCE Growing Systems, Ltd. AGRI shares shot up 143% to $5.25. AgriFORCE Growing Systems reported binding LOI to acquire a European
agriculture/horticulture and AgTech consulting firm for $29 million.
Shares of Enphase Energy, Inc. ENPH got a boost, shooting 21% to $210.64 after the company reported better-than-expected Q3 results and issued Q4 sales guidance above estimates.
Silicon Laboratories Inc. SLAB shares were also up, gaining 15% to $178.13 after the company reported better-than-expected Q3 results and issued Q4 adjusted EPS guidance above estimates.
Check out these big movers of the day
Equities Trading DOWN
Cortexyme, Inc. CRTX shares tumbled 74% to $14.96 after the company shared an update. Cortexyme reported Phase 2/3 GAIN trial data for its Alzheimer’s disease trial. The company stated co-primary endpoints were not met for ADAS-Cog11 and ADCS-ADL in the overall population. Subgroups saw a 50% slowing level for infection for ADAS-Cog11.
Shares of Angion Biomedica Corp. ANGN were down 54% to $4.0050. After flopping a test in COVID-19 earlier this year, Angion Biomedica’s lead candidate drug has hit a setback again, this time in kidney transplant patients. Angion and partner Vifor Pharma's ANG-3777 failed to beat placebo in terms of improving eGFR, a measure of kidney function, in patients who received a deceased donor kidney transplant and were at high risk of developing delayed graft function.
DBV Technologies S.A. DBVT was down, falling 28% to $3.64 after the company reported a loss for the third quarter.
Commodities
In commodity news, oil traded down 1.7% to $83.24, while gold traded down 0.1% to $1,792.90.
Silver traded up 0.3% Wednesday to $24.165 while copper fell 2% to $4.3975.
Euro zone
European shares were lower today. The eurozone’s STOXX 600 fell 0.42%, the Spanish Ibex Index fell 0.35% and the German DAX 30 declined 0.36%. Meanwhile, the London’s FTSE 100 fell 0.29%, French CAC 40 fell 0.23% and Italy’s FTSE MIB declined 0.71%.
Loans to households in the Eurozone climbed 4.1% year-over-year in September. Industrial producer prices in the France’s domestic market rose 1.7% from a month ago in September, while consumer confidence declined to 99 in October from a revised level of 101 in September.
Import prices in Germany rose 17.7% year-over-year in September, while GfK consumer climate indicator rose to 0.9 heading into November.
Economics
US durable goods orders fell 0.4% for September.
The US goods trade deficit widened to $96.25 billion in September.
US wholesale inventories increased 1.1% to $739.5 billion for September.
US crude oil inventories climbed 4.267 million barrels in the week ending October 22, following a 0.431 million drop in the prior period, the Energy Information Administration said.
The Treasury is set to auction 5-year notes at 1:00 p.m. ET.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
